Cancer News and Research

Latest Cancer News and Research

CBT, PE can ameliorate treatment-induced menopausal symptoms in breast cancer patients

Researchers from The Netherlands have found that the menopausal symptoms caused by giving chemotherapy or hormonal therapy to younger women with breast cancer can be ameliorated considerably through the use of cognitive behavioural therapy (CBT) and physical exercise.

23 Mar 2012

BUMC to open first dedicated cancer hospital in North Texas

Baylor University Medical Center at Dallas is opening Baylor Cancer Hospital, the region's first dedicated cancer hospital beginning in early 2012. The cancer hospital will provide inpatient cancer care services, a 24-hour oncology evaluation and treatment center, as well as an array of support services to cancer patients, their families and caregivers.

23 Mar 2012

OncoSec to present data from head and neck cancer studies at two upcoming conferences

OncoSec Medical Incorporated., which is developing its advanced-stage OncoSec Medical System (OMS) ElectroOncology therapies to treat solid tumor cancers, today announced that the company has been selected to present data from its Phase III and IV head and neck cancer studies at two upcoming conferences.

23 Mar 2012

Nearly three in five Kentuckians believe pain is just a part of life

New research released today finds that pain affects the majority of Kentuckians, yet most underestimate its severity and the need for effective treatment. The survey by the American Osteopathic Association (AOA) uncovered that nearly three in five Kentuckians believe pain is just a part of life and two in five don't believe it can be eased with proper treatment.

23 Mar 2012

Cardiff team receives European grants to develop 'RealTCut' surgical simulation

Highly realistic surgical simulation which reduces patient risk has become the 100th Cardiff University project to win an award under the European Union's prime research funding scheme, the Seventh Framework Programme.

23 Mar 2012

IBM, MSKCC partner to develop decision support tool for oncologists

Memorial Sloan-Kettering Cancer Center (MSKCC) and IBM have agreed to collaborate on the development of a powerful tool built upon IBM Watson in order to provide medical professionals with improved access to current and comprehensive cancer data and practices.

23 Mar 2012

Lawmakers allege some drug companies inflate cost of scarce drugs with 'fake pharmacies'

Rep. Elijah Cummings, D-Md., is leading a congressional investigation accusing some drug distributors of opening "fake pharmacies" to drive up the cost of some pharmacueticals that are in short supply.

23 Mar 2012

RT after surgery could reduce chances of local DCIS recurrence by 50%

Radiotherapy treatment (RT) after surgery for ductal carcinoma in situ (DCIS) still has a major protective effect against recurrence more than 15 years later, according to the results of an international trial.

23 Mar 2012

Blocking PFKFB4 enzyme could prevent growth of prostate cancer cells

Cancer Research UK scientists have discovered how blocking a key enzyme, which helps convert glucose into energy, could provide a new way to kill prostate cancer cells, according to a study published in the journal Cancer Discovery.

23 Mar 2012

HCC patients have reduced risk of waitlist mortality

New research shows increasing disparity in mortality among candidates with and without hepatocellular carcinoma (HCC) who are on the waiting list for liver transplantation. The study available in the April issue of Liver Transplantation, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases, found that liver cancer patients are less likely to die on the wait list than non-HCC candidates, prompting transplantation specialists to suggest a reevaluation of current allotment criteria for those with HCC.

23 Mar 2012

tAI could predict sensitivity to chemotherapy in patients with triple-negative breast cancer

Scientists have uncovered a marker of DNA damage that could predict who will respond to platinum-based chemotherapy drugs like cisplatin or carboplatin.

23 Mar 2012

PFKFB4 gene leads to excessive growth of prostate cancer cells

Cancer cell metabolism may present a new target for therapy as scientists have uncovered a possible gene that leads to greater growth of prostate cancer cells.

23 Mar 2012

WCI technique uses MRS to detect oncometabolites

Researchers at Winship Cancer Institute have developed a technique for detecting an "oncometabolite", a chemical produced by some brain tumors' warped metabolism, via non-invasive imaging.

23 Mar 2012

Physicians preferred over online sources for information by parents of pediatric cancer patients

Parents and adult caregivers of pediatric cancer patients prefer personal consultations with trusted health care providers over online sources for information about their child's illness, according to a University at Buffalo research study.

22 Mar 2012

Population-based mammography programmes still save significant number of lives

A Dutch study of the effectiveness of breast cancer screening shows that, even with improved treatments for the disease, population-based mammography programmes still save a significant number of lives.

22 Mar 2012

First Edition: March 22, 2012

Today's headlines include examinations of the health law as it approaches its two-year anniversary and its review by the Supreme Court, as well as reports about what's next for the Ryan budget plan.

22 Mar 2012

Study identifies ROS in the gaseous phase of cigarette smoke

A team of researchers led by A. K. Rajasekaran, PhD, Director of the Nemours Center for Childhood Cancer Research, has shown that a key protein involved in cell function and regulation is stopped by a substance present in cigarette smoke.

22 Mar 2012

Study demonstrates molecular mechanisms of cadmium-induced prostate cancer

A recent study conducted at Marshall University may eventually help scientists develop new treatments for prostate cancer, the most common malignancy in American men.

22 Mar 2012

CINJ clinical trials leader receives 2012 Award of Excellence from HOPA

Susan Goodin, PharmD, FCCP, BCOP, associate director of clinical trials and therapeutics at The Cancer Institute of New Jersey (CINJ) has received the 2012 Award of Excellence from the Hematology/Oncology Pharmacy Association.

22 Mar 2012

Opioids may influence breast cancer survival

A new study in the April issue of Anesthesiology analyzed inherited (genetic) differences in how the body responds to its own morphine-like chemicals and pain-relieving opioid drugs, and whether they influence breast cancer survival. Preclinical animal studies have suggested that opioids may promote tumor growth.

22 Mar 2012